A detailed history of State Of Alaska, Department Of Revenue transactions in Alkermes Plc. stock. As of the latest transaction made, State Of Alaska, Department Of Revenue holds 93,969 shares of ALKS stock, worth $2.59 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
93,969
Previous 99,353 5.42%
Holding current value
$2.59 Million
Previous $2.39 Million 9.86%
% of portfolio
0.03%
Previous 0.03%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$23.01 - $28.55 $123,885 - $153,713
-5,384 Reduced 5.42%
93,969 $2.63 Million
Q2 2024

Aug 05, 2024

SELL
$23.21 - $27.24 $53,591 - $62,897
-2,309 Reduced 2.27%
99,353 $2.39 Million
Q1 2024

Apr 19, 2024

SELL
$26.4 - $32.56 $26,479 - $32,657
-1,003 Reduced 0.98%
101,662 $2.75 Million
Q4 2023

Jan 19, 2024

BUY
$23.37 - $28.68 $2.4 Million - $2.94 Million
102,665 New
102,665 $2.85 Million
Q3 2019

Oct 02, 2019

SELL
$19.51 - $24.28 $350,926 - $436,724
-17,987 Closed
0 $0
Q2 2019

Jul 23, 2019

BUY
$21.47 - $37.33 $858 - $1,493
40 Added 0.22%
17,987 $405,000
Q1 2019

Apr 09, 2019

SELL
$28.4 - $36.49 $29,820 - $38,314
-1,050 Reduced 5.53%
17,947 $654,000
Q4 2018

Jan 10, 2019

BUY
$27.94 - $44.61 $4,274 - $6,825
153 Added 0.81%
18,997 $560,000
Q3 2018

Oct 09, 2018

BUY
$38.6 - $46.12 $11,348 - $13,559
294 Added 1.58%
18,844 $799,000
Q2 2018

Jul 10, 2018

BUY
$40.56 - $51.36 $183,736 - $232,660
4,530 Added 32.31%
18,550 $763,000
Q1 2018

Apr 19, 2018

BUY
$53.61 - $67.26 $151,180 - $189,673
2,820 Added 25.18%
14,020 $812,000
Q4 2017

Jan 19, 2018

BUY
$47.69 - $55.39 $534,128 - $620,368
11,200
11,200 $612,000

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.53B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track State Of Alaska, Department Of Revenue Portfolio

Follow State Of Alaska, Department Of Revenue and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Alaska, Department Of Revenue, based on Form 13F filings with the SEC.

News

Stay updated on State Of Alaska, Department Of Revenue with notifications on news.